The modification of Sp3 isoforms by SUMOylation has differential effects on the SRC1A promoter

Gene

Volumn 379, Issue 1-2, 2006, Pages 68-78

  Ellis, Danielle J P ^a,b   Dehm, Scott M ^a,b   Bonham, Keith ^a  

^a SASKATCHEWAN CANCER AGENCY   (Canada)

^b UNIVERSITY OF SASKATCHEWAN   (Canada)

Author keywords

Acetylation; Sp1; SRC; Transcriptional regulation

Indexed keywords

ISOPROTEIN; STEROID RECEPTOR COACTIVATOR 1; STEROID RECEPTOR COACTIVATOR 1A; SUMO PROTEIN; TRANSCRIPTION FACTOR SP3; UNCLASSIFIED DRUG;

AMINO TERMINAL SEQUENCE; ANIMAL CELL; ARTICLE; CONTROLLED STUDY; GENE ACTIVATION; GENE CONTROL; GENE MUTATION; HUMAN; HUMAN CELL; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN ANALYSIS; PROTEIN MODIFICATION; TRANSACTIVATION;

ANIMALS; BINDING SITES; CELL LINE, TUMOR; CELLS, CULTURED; DROSOPHILA MELANOGASTER; HUMANS; MODELS, GENETIC; PROMOTER REGIONS (GENETICS); PROTEIN ISOFORMS; PROTO-ONCOGENE PROTEINS PP60(C-SRC); SP3 TRANSCRIPTION FACTOR; SUMO-1 PROTEIN; TRANS-ACTIVATION (GENETICS); TRANSFECTION;

INSECTA; MAMMALIA;

EID: 33747329116     PISSN: 03781119     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.gene.2006.04.015     Document Type: Article

References (35)

1. Aligayer H., Boyd D.D., Heiss M.M., Abdalla E.K., Curley S.A., and Gallick G.E. Activation of Src kinase in primary colorectal carcinoma: an indicator of poor clinical prognosis. Cancer 94 (2002) 341-355
2. Ammanamanchi S., Freeman J.W., and Brattain M.G. Acetylated Sp3 is a transcriptional activator. J. Biol. Chem. 278 (2003) 35775-35780
3. Bakovic M., Waite K., and Vance D.E. Oncogenic Ha-Ras transformation modulates the transcription of the CTP: phosphocholine cytidylyltransferase alpha gene via p42/44MAPK and transcription factor Sp3. J. Biol. Chem. 278 (2003) 14753-14761
4. Birnbaum M.J., et al. Sp1 trans-activation of cell cycle regulated promoters is selectively repressed by Sp3. Biochemistry 34 (1995) 16503-16508
5. Biscardi J.S., Tice D.A., and Parsons S.J. c-Src, receptor tyrosine kinases, and human cancer. Adv. Cancer Res. 76 (1999) 61-119
6. Bjorge J.D., Jakymiw A., and Fujita D. Selected glimpses into the activation and function of Src kinase. Oncogene 19 (2000) 5620-5635
7. Bonham K., Ritchie S.A., Dehm S.M., Snyder K., and Boyd F.M. An alternative, human SRC promoter and its regulation by hepatic nuclear factor-1alpha. J. Biol. Chem. 275 (2000) 37604-37611
8. Brasse-Lagnel C., Fairand A., Lavoinne A., and Husson A. Glutamine stimulates argininosuccinate synthetase gene expression through cytosolic O-glycosylation of Sp1 in Caco-2 cells. J. Biol. Chem. 278 (2003) 52504-52510
9. Braun H., Koop R., Ertmer A., Nacht S., and Suske G. Transcription factor Sp3 is regulated by acetylation. Nucleic Acids Res. 29 (2001) 4994-5000
10. Cam W.R., et al. Reduced C-terminal Src kinase activity is correlated inversely with pp60(c-src) activity in colorectal carcinoma. Cancer 92 (2001) 61-70
11. De Luca P., Majello B., and Lania L. Sp3 represses transcription when tethered to promoter DNA or targeted to promoter proximal RNA. J. Biol. Chem. 271 (1996) 8533-8536
12. De Nadal E., Zapater M., Alepuz P.M., Sumoy L., Mas G., and Posas F. The MAPK Hog1 recruits Rpd3 histone deacetylase to activate osmoresponsive genes. Nature 427 (2004) 370-374
13. Dehm S., Senger M.A., and Bonham K. SRC transcriptional activation in a subset of human colon cancer cell lines. FEBS Lett. 487 3 (2001) 367-371
14. Dehm S.M., Hilton T.L., Wang E.H., and Bonham K. SRC proximal and core promoter elements dictate TAF1 dependence and transcriptional repression by histone deacetylase inhibitors. Mol. Cell. Biol. 24 (2004) 2296-2307
15. Dennig J., Beato M., and Suske G. An inhibitor domain in Sp3 regulates its glutamine-rich activation domains. EMBO J. 15 (1996) 5659-5667
16. Egan C., Pang A., Durda D., Heung-Chen C., Wang J., and Fujita D. Activation of Src in human breast tumor cell lines: elevated levels of phosphotyrosine phosphatase activity that preferentially recognizes the Src carboxy terminal negative regulatory tyrosine 530. Oncogene 18 (1999) 1227-1237
17. Frame M.C. Src in cancer: deregulation and consequences for cell behaviour. Biochim. Biophys. Acta 1602 (2002) 114-130
18. Kennett S., Udvadia A.J., and Horowitz J.M. Sp3 encodes multiple proteins that differ in their capacity to stimulate or repress transcription. Nucleic Acids Res. 25 (1997) 3110-3117
19. Kennett S., Moorfield K.S., and Horrowitz J. Sp3 represses gene expression via the titration of promoter-specific transcription factors. J. Biol. Chem. 277 (2002) 9780-9789
20. Kingsley C., and Winoto A. Cloning of GT box-binding proteins: a novel Sp1 multigene family regulating T-cell receptor gene expression. Mol. Cell. Biol. 12 (1992) 4251-4261
21. Lania L., Majello B., and De Luca P. Transcriptional regulation by the Sp family proteins. Int. J. Biochem. Cell Biol. 29 (1997) 1313-1323
22. Li L., He S., Sun J., and Davie J. Gene regulation by Sp1 and Sp3. Biochem. Cell. Biol. 82 (2004) 460-471
23. Mastrangelo I.A., Courey A.J., Wall J.S., Jackson S.P., and Hough P.V. DNA looping and Sp1 multimer links: a mechanism for transcriptional synergism and enhancement. Proc. Natl. Acad. Sci. U. S. A. 88 (1991) 5670-5674
24. Ritchie S., Boyd F.M., Wong J., and Bonham K. Transcription of the human c-Src promoter is dependent on Sp1, a novel pyrimidine binding factor SPy, and can be inhibited by triplex-forming oligonucleotides. J. Biol. Chem. 275 (2000) 847-854
25. Ritchie S.A., et al. Identification of the SRC pyrimidine-binding protein (SPy) as hnRNP K: implications in the regulation of SRC1A transcription. Nucleic Acids Res. 31 5 (2003) 1-12
26. Ross S., Best J.L., Zon L.I., and Gill G. SUMO-1 modification represses Sp3 transcriptional activation and modulates its subnuclear localization. Mol. Cell 10 (2002) 831-842
27. Sapetschnig A., et al. Transcription factor Sp3 is silenced through SUMO modification by PIAS1. EMBO J. 21 (2002) 5206-5215
28. Sapetschnig A., Koch F., Rischitor G., Mennenga T., and Suske G. Complexity of translationally controlled transcription factor Sp3 isoform expression. J. Biol. Chem. 279 (2004) 42095-42105
29. Sowa Y., Orita T., Minamikawa-Hiranabe S., Mizuno T., Nomura H., and Sakai T. Sp3, but not Sp1, mediates the transcriptional activation of the p21/WAF1/Cip1 gene promoter by histone deacetylase inhibitor. Cancer Res. 59 (1999) 4266-4270
30. Splenger M.L., Kennett S.B., Moorfield K.S., Simmons S.O., Brittain M.G., and Horowitz J.M. Sumoylation of internally initiated Sp3 isoforms regulates transcriptional repression via a Trichostatin A-insensitive mechanism. Cell. Signal. 17 (2005) 153-166
31. Su W., Jackson S., Tjian R., and Echols H. DNA looping between sites for transcriptional activation: self-association of DNA-bound Sp1. Genes Dev. 5 (1991) 820-826
32. Suske G. The Sp-family of transcription factors. Gene 238 (1999) 291-300
33. Tang S., et al. Evidence that Sp1 positively and Sp3 negatively regulate and androgen does not directly regulate functional tumor suppressor 15-lipoxygenase 2 (15-LOX2) gene expression in normal human prostate epithelial cells. Oncogene 23 (2004) 6942-6953
34. Wong C.F., et al. E2F suppression and Sp1 overexpression are sufficient to induce the differentiation-specific marker, transglutaminase type 1, in a squamous cell carcinoma cell line. Oncogene 24 21 (2005) 3525-3534
35. Ye X., and Liu S. Lipopolysaccharide down-regulates Sp1 binding activity by promoting Sp1 protein dephosphorylation and degradation. J. Biol. Chem. 277 (2002) 31863-31870